On 13 December 2023, the Global Accelerator for Paediatric formulations (GAP-f) partners co-hosted a session at the 2nd International Paediatric HIV Symposium in Africa (IPHASA) on Accelerating access to better medicines for children: ensuring successful introduction of paediatric abacavir/lamivudine/dolutegravir (pALD) fixed-dose combination and sustainability of pDTG.

Access the recording of the session

Access the GAP-f memo on Paediatric Abacavir/Lamivudine/Dolutegravir (pALD) fixed-dose combination: Introduction and rollout planning considerations for national programmes